Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Netflix (NFLX) Adds New Content Driver As Subscription Growth Decelerates

Published 07/21/2021, 01:08 AM
Updated 07/09/2023, 06:31 AM

Netflix (NASDAQ:NFLX)'s NFLX Q2 earnings hit the wire after the bell on Tuesday (7/20) with some indecisive price action in after-hours trading to a slide in Wednesday's session. A miss on EPS and subscription estimates, along with weak Q3 guidance, drove NFLX shares down over 5% lower immediately on the print. However, as investors and traders continued to study the quarterly report, they realized that they might be punishing this relatively discounted growth stock a little too harshly.

NFLX has traded sideways for over 52-weeks, just waiting for an upside catalyst, and despite some initially disappointing figures, there were positive underlying takeaways from this quarter.

A New Subscription Growth Driver

The most important announcement in this earnings report was related to Netflix's new gaming endeavor. Netflix had stated that it would be taking on the expanding digital gaming space and announced that former FB video-game executive Mike Verdu would be at the helm of this new venture earlier this month. The delivery of this new content segment was unclear until this report, which laid out its plan a little more clearly.

Netflix is in the early stages of game development, stating that the new mobile games would be included in Netflix's current subscription package with no additional costs. Here's what they had to say in their quarterly release: "We're also in the early stages of further expanding into games, building on our earlier efforts around interactivity (e.g., Black Mirror Bandersnatch) and our Stranger Things games. We view gaming as another new content category for us, similar to our expansion into original films, animation and unscripted TV. Games will be included in members' Netflix subscription at no additional cost, similar to films and series. Initially, we'll be primarily focused on games for mobile devices."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This could be the additional content driver that Netflix needs to propel its decelerating global subscription growth back into overdrive.

The stock traded lower on Wednesday as investors weighed the potential subscription expansion with this division's increase to capital spending. NFLX went cash-flow positive for the first time in nearly nine years (when it began creating original content) last quarter, with 200+ million subscribers appearing to be the magic number for its enormous content creation budget to be sustainable. This content budget just grew with its gaming unit launch, and shareholders are trading it defensively on the implication that subscription appreciation may not outpace its content budget growth.

Final Thoughts

Keep in mind that Netflix is still facing mounting competition in streaming as Disney+ DIS and HBO Max T take share. The gaming space is facing similar saturation with Google GOOGL, Microsoft MSFT, Apple AAPL, and Amazon AMZN all investing heavily.

If you believe in the Netflix narrative, you may consider jumping into the streaming king on this post-earnings dip. This quarterly report didn’t illustrate any systemic issues in either its results or forward guidance, and the additional topline driver only enhances its arsenal of consumer demanded content. NFLX is trading at its lowest valuation level in about a decade (since its streaming service took off) and sizably below most analysts' price targets.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amazon.com, Inc. (NASDAQ:AMZN): Free Stock Analysis Report

AT&T Inc. (T): Free Stock Analysis Report

Apple Inc. (NASDAQ:AAPL): Free Stock Analysis Report

Microsoft Corporation (NASDAQ:MSFT): Free Stock Analysis Report

Netflix, Inc. (NFLX): Free Stock Analysis Report

The Walt Disney Company (NYSE:DIS): Free Stock Analysis Report

Alphabet Inc. (NASDAQ:GOOGL): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.